Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Ali Passian
- Ryan Dehoff
- Michael Kirka
- Vincent Paquit
- Adam Stevens
- Ahmed Hassen
- Alex Plotkowski
- Alice Perrin
- Amir K Ziabari
- Amit Shyam
- Andres Marquez Rossy
- Blane Fillingim
- Brian Post
- Bruce Moyer
- Christopher Ledford
- Claire Marvinney
- Clay Leach
- David Nuttall
- Debjani Pal
- Harper Jordan
- James Haley
- Jeffrey Einkauf
- Jennifer M Pyles
- Joel Asiamah
- Joel Dawson
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mike Zach
- Nance Ericson
- Padhraic L Mulligan
- Patxi Fernandez-Zelaia
- Peeyush Nandwana
- Philip Bingham
- Rangasayee Kannan
- Roger G Miller
- Sandra Davern
- Sarah Graham
- Singanallur Venkatakrishnan
- Srikanth Yoginath
- Sudarsanam Babu
- Varisara Tansakul
- Vipin Kumar
- Vlastimil Kunc
- William Peter
- Yan-Ru Lin
- Ying Yang
- Yukinori Yamamoto

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

High strength, oxidation resistant refractory alloys are difficult to fabricate for commercial use in extreme environments.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

In manufacturing parts for industry using traditional molds and dies, about 70 percent to 80 percent of the time it takes to create a part is a result of a relatively slow cooling process.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

Technologies directed quantum spectroscopy and imaging with Raman and surface-enhanced Raman scattering are described.